STONY BROOK, N.Y., Aug. 23, 2016 (GLOBE NEWSWIRE) -- Applied DNA Sciences, Inc. (Applied DNA)
(NASDAQ:APDN) a provider of DNA-based supply-chain, anti-counterfeiting and anti-theft technology, product genotyping and product
authentication solutions, has been invited to present at the 2016 Gateway Conference being held on September 7-8, 2016 at the Four Seasons Hotel San
Francisco.
Applied DNA Sciences management is scheduled to present on Thursday, September 8 at 2:30 pm. Pacific time, with one-on-one
meetings held throughout the conference.
The presentation will be webcast live and available for replay in the Investor Relations section of Applied DNA’s website at
www.adnas.com or on the Gateway Conference website at www.gateway-conference.com/presenters.
To receive additional information, request an invitation or to schedule a one-on-one meeting, please email gateway@liolios.com.
About the Gateway Conference
The 5th Annual Gateway Conference is an invite-only conference presented by Liolios, which brings together the most
compelling companies with the nation’s top institutional investors and analysts. This year’s event features more than 100 companies
from a number of growth industries, including technology, business and financial services, consumer, digital media, clean
technology and life sciences. The format has been designed to give attendees direct access to senior management via company
presentations, Q&A sessions and one-on-one meetings. For more information, visit www.gateway-conference.com or www.liolios.com.
About Applied DNA Sciences
We make life real and safe by providing botanical-DNA based security and authentication solutions and services that can help
protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft,
counterfeiting, fraud and diversion. Our patented DNA-based solutions can be used to identify, tag, track, and trace products, to
help assure authenticity, traceability and quality of products. SigNature® DNA describes the platform ingredient that is at the
heart of a family of uncopyable, security and authentication solutions such as SigNature® T and fiberTyping®, targeted toward
textiles and apparel, DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track and trace. All provide
a forensic chain of evidence, and can be used to prosecute perpetrators. We are also engaged in the large-scale production of
specific DNA sequences using the polymerase chain reaction.
Go to adnas.com for more information, events and to learn more about how Applied DNA Sciences makes life real
and safe. Common stock listed on NASDAQ under the symbol APDN, and warrants are listed under the symbol APDNW.
Forward Looking Statements
The statements made by APDN in this press release may be “forward-looking” in nature within the meaning of the Private Securities
Litigation Act of 1995. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are
based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results
could differ materially from those projected due to our short operating history, limited financial resources, limited market
acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including
our Annual Report on Form 10-K filed on December 14, 2015, and our subsequent quarterly report on Form 10-Q filed on February 10,
2016, May 12, 2016 and August 11, 2016 that are available at www.sec.gov. APDN undertakes no obligation to update publicly any
forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of
unanticipated events, unless otherwise required by law.
Investor contact: Debbie Bailey, 631-240-8817, debbie.bailey@adnas.com Media contact: Susan Forman, Dian Griesel Int’l., 212-825-3210, sforman@dgicomm.com web: www.adnas.com twitter: @APDN
